$8.66M Market Cap.
ICU Market Cap. (MRY)
ICU Shares Outstanding (MRY)
ICU Assets (MRY)
Total Assets
$4.66M
Total Liabilities
$6.84M
Total Investments
$0
ICU Income (MRY)
Revenue
$135.00K
Net Income
-$24.83M
Operating Expense
$17.98M
ICU Cash Flow (MRY)
CF Operations
-$16.01M
CF Investing
$0
CF Financing
$17.65M
ICU Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | - | - | - | - |
ICU Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $4,658,000 (32.59%) | $3,513,000 (-26.31%) | $4,767,000 (690.55%) | $603,000 (-79.27%) |
Assets Current | $3,766,000 (63.17%) | $2,308,000 (-23.98%) | $3,036,000 (405.16%) | $601,000 (-79.33%) |
Assets Non-Current | $892,000 (-25.98%) | $1,205,000 (-30.39%) | $1,731,000 (86450.00%) | $2,000 (0.00%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | -$2,183,000 (84.26%) | -$13,870,000 (-68.43%) | -$8,235,000 (-192.44%) | -$2,816,000 (96.07%) |
Property Plant & Equipment Net | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cash & Equivalents | $1,819,000 (933.52%) | $176,000 (274.47%) | $47,000 (-90.78%) | $510,000 (-81.83%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $112,000 (0%) | $0 (0%) | $12,000 (-79.31%) | $58,000 (0%) |
Trade & Non-Trade Payables | $3,046,000 (-30.33%) | $4,372,000 (126.88%) | $1,927,000 (2167.06%) | $85,000 (-77.75%) |
Accumulated Retained Earnings (Deficit) | -$139,564,000 (-21.64%) | -$114,734,000 (-15.51%) | -$99,325,000 (-30.16%) | -$76,312,000 (-6.41%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $574,000 (-93.68%) | $9,081,000 (2.84%) | $8,830,000 (229.85%) | $2,677,000 (3125.30%) |
Debt Current | $574,000 (-87.90%) | $4,744,000 (302.72%) | $1,178,000 (-50.46%) | $2,378,000 (11790.00%) |
Debt Non-Current | $0 (0%) | $4,337,000 (-43.32%) | $7,652,000 (2459.20%) | $299,000 (374.60%) |
Total Liabilities | $6,841,000 (-60.65%) | $17,383,000 (33.69%) | $13,002,000 (280.29%) | $3,419,000 (199.13%) |
Liabilities Current | $6,841,000 (-47.56%) | $13,046,000 (143.85%) | $5,350,000 (71.47%) | $3,120,000 (188.89%) |
Liabilities Non-Current | $0 (0%) | $4,337,000 (-43.32%) | $7,652,000 (2459.20%) | $299,000 (374.60%) |
ICU Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $135,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $8,872,000 (7.71%) | $8,237,000 (24.80%) | $6,600,000 (292.16%) | $1,683,000 (-30.68%) |
Research & Development Expense | $9,105,000 (52.44%) | $5,973,000 (111.88%) | $2,819,000 (1.92%) | $2,766,000 (-31.28%) |
Operating Expenses | $17,977,000 (26.51%) | $14,210,000 (22.41%) | $11,609,000 (160.94%) | $4,449,000 (-31.06%) |
Interest Expense | $244,000 (-77.43%) | $1,081,000 (71.59%) | $630,000 (197.17%) | $212,000 (-93.59%) |
Income Tax Expense | $3,000 (0%) | $0 (0%) | $1,000 (200.00%) | -$1,000 (-111.11%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$24,830,000 (5.34%) | -$26,232,000 (-13.99%) | -$23,013,000 (-400.72%) | -$4,596,000 (-40.29%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$24,830,000 (5.34%) | -$26,232,000 (-13.99%) | -$23,013,000 (-400.72%) | -$4,596,000 (-40.29%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$24,830,000 (5.34%) | -$26,232,000 (-13.99%) | -$23,013,000 (-400.72%) | -$4,596,000 (-40.29%) |
Weighted Average Shares | $3,743,554 (-82.72%) | $21,670,330 (163.91%) | $8,211,256 (13.43%) | $7,238,767 (235.71%) |
Weighted Average Shares Diluted | $3,743,554 (-82.72%) | $21,670,330 (163.91%) | $8,211,256 (13.43%) | $7,238,767 |
Earning Before Interest & Taxes (EBIT) | -$24,583,000 (2.26%) | -$25,151,000 (-12.37%) | -$22,382,000 (-410.42%) | -$4,385,000 (-10795.12%) |
Gross Profit | $135,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$17,842,000 (-25.56%) | -$14,210,000 (-22.41%) | -$11,609,000 (-160.94%) | -$4,449,000 (31.06%) |
ICU Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $17,650,000 (69.48%) | $10,414,000 (42.05%) | $7,331,000 (160.24%) | $2,817,000 (-42.42%) |
Net Cash Flow from Operations | -$16,007,000 (-55.63%) | -$10,285,000 (-31.96%) | -$7,794,000 (-52.41%) | -$5,114,000 (8.22%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $1,643,000 (1173.64%) | $129,000 (127.86%) | -$463,000 (79.84%) | -$2,297,000 (-237.79%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | -$3,557,000 (-198.21%) | $3,622,000 (4.05%) | $3,481,000 (23.57%) | $2,817,000 (2218.05%) |
Issuance (Purchase) of Equity Shares | $17,441,000 (163.78%) | $6,612,000 (-6.08%) | $7,040,000 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $887,000 (-54.04%) | $1,930,000 (47.22%) | $1,311,000 (9264.29%) | $14,000 (0%) |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
ICU Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% | - | - | - |
Profit Margin | -18392.60% | - | - | - |
EBITDA Margin | -18209.60% | - | - | - |
Return on Average Equity (ROAE) | 636.30% (215.94%) | 201.40% (-51.64%) | 416.50% (-67.83%) | 1294.50% |
Return on Average Assets (ROAA) | -485.60% (46.87%) | -914.00% (-6.64%) | -857.10% (-14936.84%) | -5.70% |
Return on Sales (ROS) | -18209.60% | - | - | - |
Return on Invested Capital (ROIC) | 658.40% (-94.59%) | 12179.70% (2236.04%) | -570.20% (-10267.27%) | -5.50% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.29 (19.95%) | -0.37 (75.00%) | -1.46 (90.81%) | -15.94 |
Price to Sales Ratio (P/S) | 53.8 | - | - | - |
Price to Book Ratio (P/B) | -3.97 (-236.10%) | -1.18 (81.34%) | -6.32 (86.40%) | -46.49 |
Debt to Equity Ratio (D/E) | -3.13 (-150.12%) | -1.25 (20.65%) | -1.58 (-30.07%) | -1.21 (-7487.50%) |
Earnings Per Share (EPS) | -6.63 (-447.93%) | -1.21 (56.79%) | -2.8 (-344.44%) | -0.63 (0%) |
Sales Per Share (SPS) | 0.04 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -4.28 (-800.21%) | -0.47 (49.95%) | -0.95 (-34.42%) | -0.71 (72.68%) |
Book Value Per Share (BVPS) | -0.58 (8.91%) | -0.64 (36.19%) | -1 (-157.84%) | -0.39 (98.83%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.24 (667.90%) | 0.16 (-72.12%) | 0.58 (600.00%) | 0.08 (-93.85%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | -1 (66.67%) | -3 (90.00%) | -30 |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.27 (74.50%) | -1.05 (58.65%) | -2.54 (91.48%) | -29.82 |
Asset Turnover | 0.03 (0%) | 0 (0%) | 0 (0%) | 0 |
Current Ratio | 0.55 (211.30%) | 0.18 (-68.78%) | 0.57 (193.78%) | 0.19 (-92.83%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$16,007,000 (-55.63%) | -$10,285,000 (-31.96%) | -$7,794,000 (-52.41%) | -$5,114,000 (8.22%) |
Enterprise Value (EV) | $6,576,507 (-75.11%) | $26,424,924 (-53.55%) | $56,892,639 (-56.49%) | $130,764,496 |
Earnings Before Tax (EBT) | -$24,827,000 (5.36%) | -$26,232,000 (-13.99%) | -$23,012,000 (-400.59%) | -$4,597,000 (-40.71%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$24,583,000 (2.26%) | -$25,151,000 (-12.37%) | -$22,382,000 (-410.42%) | -$4,385,000 (-10795.12%) |
Invested Capital | -$3,428,000 (-445.86%) | -$628,000 (-107.66%) | $8,200,000 (2442.86%) | -$350,000 (60.89%) |
Working Capital | -$3,075,000 (71.36%) | -$10,738,000 (-364.04%) | -$2,314,000 (8.14%) | -$2,519,000 (-237.88%) |
Tangible Asset Value | $4,658,000 (32.59%) | $3,513,000 (-26.31%) | $4,767,000 (690.55%) | $603,000 (-79.27%) |
Market Capitalization | $8,658,507 (-47.11%) | $16,370,924 (-68.56%) | $52,068,639 (-60.23%) | $130,930,336 |
Average Equity | -$3,902,250 (70.04%) | -$13,026,250 (-135.75%) | -$5,525,500 (-1456.33%) | -$355,034 |
Average Assets | $5,112,750 (78.14%) | $2,870,000 (6.89%) | $2,685,000 (-96.65%) | $80,041,789 |
Invested Capital Average | -$3,733,500 (-1707.99%) | -$206,500 (-105.26%) | $3,925,000 (-95.05%) | $79,361,358 |
Shares | 4,463,148 (-87.93%) | 36,979,724 (191.19%) | 12,699,668 (-2.62%) | 13,041,000 |
